A novel nomogram based on DNA damage response-related gene expression in patients with O-6-methylguanine-DNA methyltransferase unmethylated glioblastoma receiving temozolomide chemotherapy: A population-based analysis
Background and Aim: Glioblastoma (GBM) is the most lethal primary brain tumor. Patients with unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) promoter have higher MGMT expression, are less sensitive to temozolomide (TMZ), and are linked to poor prognosis. The aim of this study was to iden...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| coleção: | Glioma |
| Assuntos: | |
| Acesso em linha: | http://www.jglioma.com/article.asp?issn=2589-6113;year=2022;volume=5;issue=1;spage=20;epage=28;aulast=Wang |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
